RE:RE:RE:IMMU type buyout takes us to $220/share
Reports said that SORT1 expression level could be lower in earlier stage. Since higher SORT1 expression level likely result in higher effectiveness despite the poc haven't been demonstrated. I think this is why TH target to late stage cancer.